Guizhou Yibai Pharmaceutical Co Ltd (600594) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Based on the latest financial reports, Guizhou Yibai Pharmaceutical Co Ltd (600594) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.28 Million ≈ $4.87 Million USD) by net assets (CN¥2.52 Billion ≈ $368.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600594 equity to assets ratio to measure how much of total assets are equity-financed.

Guizhou Yibai Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Guizhou Yibai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Guizhou Yibai Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Guizhou Yibai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Yibai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hanwha Corp Preferred KO:00088K	0.032x
XMax Inc. NASDAQ:XWIN	-0.140x
Bhagiradha Chemicals & Industries Limited NSE:BHAGCHEM	-0.008x
Thaicom Public Company Limited BK:THCOM	0.017x
Tarczynski S.A. WAR:TAR	0.055x
Hillstone Networks Co Ltd SHG:688030	-0.042x
Maha Energy AB (publ) ST:MAHA-A	-0.038x
Zhejiang Extek Technology Co. Ltd. A SHE:301399	N/A

Annual Cash Flow Conversion Efficiency for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see 600594 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.27 Billion ≈ $332.26 Million	CN¥256.71 Million ≈ $37.56 Million	0.113x	+239.16%
2024-12-31	CN¥2.61 Billion ≈ $381.36 Million	CN¥86.87 Million ≈ $12.71 Million	0.033x	-73.36%
2023-12-31	CN¥3.02 Billion ≈ $441.67 Million	CN¥377.61 Million ≈ $55.26 Million	0.125x	+15.58%
2022-12-31	CN¥3.19 Billion ≈ $466.79 Million	CN¥345.30 Million ≈ $50.53 Million	0.108x	-58.72%
2021-12-31	CN¥3.56 Billion ≈ $521.30 Million	CN¥934.21 Million ≈ $136.70 Million	0.262x	+147.69%
2020-12-31	CN¥3.46 Billion ≈ $506.76 Million	CN¥366.66 Million ≈ $53.65 Million	0.106x	+8.67%
2019-12-31	CN¥3.72 Billion ≈ $544.80 Million	CN¥362.71 Million ≈ $53.08 Million	0.097x	+77.78%
2018-12-31	CN¥3.91 Billion ≈ $572.24 Million	CN¥214.30 Million ≈ $31.36 Million	0.055x	-62.69%
2017-12-31	CN¥4.64 Billion ≈ $679.20 Million	CN¥681.78 Million ≈ $99.77 Million	0.147x	+61.80%
2016-12-31	CN¥4.19 Billion ≈ $613.53 Million	CN¥380.62 Million ≈ $55.70 Million	0.091x	-43.82%
2015-12-31	CN¥3.55 Billion ≈ $519.48 Million	CN¥573.68 Million ≈ $83.95 Million	0.162x	+2.18%
2014-12-31	CN¥3.42 Billion ≈ $501.09 Million	CN¥541.58 Million ≈ $79.25 Million	0.158x	-47.05%
2013-12-31	CN¥1.93 Billion ≈ $282.78 Million	CN¥577.24 Million ≈ $84.47 Million	0.299x	+60.29%
2012-12-31	CN¥1.55 Billion ≈ $226.16 Million	CN¥288.01 Million ≈ $42.15 Million	0.186x	-23.66%
2011-12-31	CN¥1.14 Billion ≈ $166.55 Million	CN¥277.83 Million ≈ $40.65 Million	0.244x	+84.89%
2010-12-31	CN¥876.05 Million ≈ $128.19 Million	CN¥115.66 Million ≈ $16.92 Million	0.132x	-9.65%
2009-12-31	CN¥710.95 Million ≈ $104.03 Million	CN¥103.88 Million ≈ $15.20 Million	0.146x	-53.82%
2008-12-31	CN¥598.16 Million ≈ $87.53 Million	CN¥189.26 Million ≈ $27.69 Million	0.316x	+1304.16%
2007-12-31	CN¥530.04 Million ≈ $77.56 Million	CN¥11.94 Million ≈ $1.75 Million	0.023x	-89.98%
2006-12-31	CN¥425.69 Million ≈ $62.29 Million	CN¥95.77 Million ≈ $14.01 Million	0.225x	+608.46%
2005-12-31	CN¥547.39 Million ≈ $80.10 Million	CN¥17.38 Million ≈ $2.54 Million	0.032x	+135.92%
2004-12-31	CN¥506.70 Million ≈ $74.15 Million	CN¥-44.80 Million ≈ $-6.56 Million	-0.088x	-117.30%
2003-12-31	CN¥180.22 Million ≈ $26.37 Million	CN¥92.10 Million ≈ $13.48 Million	0.511x	-10.81%
2002-12-31	CN¥128.20 Million ≈ $18.76 Million	CN¥73.46 Million ≈ $10.75 Million	0.573x	--

About Guizhou Yibai Pharmaceutical Co Ltd

SHG:600594 China Drug Manufacturers - Specialty & Generic

Market Cap

$385.89 Million

CN¥2.64 Billion CNY

Market Cap Rank

#13363 Global

#3835 in China

Share Price

CN¥3.33

Change (1 day)

-1.77%

52-Week Range

CN¥2.95 - CN¥5.06

All Time High

CN¥19.64